CA2561293A1 - Traitement de l'incontinence - Google Patents

Traitement de l'incontinence Download PDF

Info

Publication number: CA2561293A1
Authority: CA; Canada
Prior art keywords: incontinence; treatment; venlafaxine; humans; administration
Prior art date: 1993-11-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002561293A

Other languages

English (en)

Other versions

CA2561293C (fr

Inventor

Karl Bruce Thor

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-24

Filing date

1994-11-18

Publication date

1995-05-25

1994-11-18 Application filed by Individual filed Critical Individual

1994-11-18 Priority claimed from CA002136120A external-priority patent/CA2136120C/fr

1995-05-25 Publication of CA2561293A1 publication Critical patent/CA2561293A1/fr

2008-03-18 Application granted granted Critical

2008-03-18 Publication of CA2561293C publication Critical patent/CA2561293C/fr

2014-11-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

206010021639 Incontinence Diseases 0.000 title 1
206010046543 Urinary incontinence Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 abstract 1
229960004688 venlafaxine Drugs 0.000 abstract 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002561293A 1993-11-24 1994-11-18 Traitement de l'incontinence Expired - Lifetime CA2561293C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15812193A	1993-11-24	1993-11-24
US08/158,121		1993-11-24
CA002136120A CA2136120C (fr)	1993-11-24	1994-11-18	Traitement de l'incontinence

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002136120A Division CA2136120C (fr)	1993-11-24	1994-11-18	Traitement de l'incontinence

Publications (2)

Publication Number	Publication Date
CA2561293A1 true CA2561293A1 (fr)	1995-05-25
CA2561293C CA2561293C (fr)	2008-03-18

Family

ID=37451524

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002561293A Expired - Lifetime CA2561293C (fr)	1993-11-24	1994-11-18	Traitement de l'incontinence

Country Status (1)

Country	Link
CA (1)	CA2561293C (fr)

1994
- 1994-11-18 CA CA002561293A patent/CA2561293C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2561293C (fr)	2008-03-18

Similar Documents

Publication	Publication Date	Title
CA2259012A1 (fr)	1998-01-29	S(-)-tolterodine pour le traitement des troubles urinaires et gastro-intestinaux
NO2005004I1 (no)	2005-02-10	Duloksetin og dets farmasøytisk akseptable syreaddisjonssalter, spesielt duloksetin hydroklorid
CA2160366A1 (fr)	1994-11-10	Pamoate de risperidone
CA2213339A1 (fr)	1996-08-29	Procede de traitement de la depletion de l'adenosine
EP0815860A3 (fr)	1998-01-14	Le carboxylate de la terfénadine et le traitement des troubles allergiques
CA2263561A1 (fr)	1998-02-19	Thienopyrimidines
CA2130805A1 (fr)	1993-09-30	Utilisation de mannose-phosphates dans le traitement des fibroses
EG20273A (en)	1998-05-31	Process for preparing of pyrazolopyrimidines and their use in the treatment of stress related and other diseases
EP1029540A3 (fr)	2001-05-16	Utilisation de la droloxifène pour le traitement de maladies cardiovasculaires
CA2272584A1 (fr)	1998-06-04	Nouveaux derives de pyrazole substitues pour le traitement de maladies cardio-vasculaires
CA2180535A1 (fr)	1995-07-13	Procede de traitement du psoriasis par omeprazole ou autres composes apparentes
CA2154103A1 (fr)	1997-01-19	Traitement des maladies, traumatismes ou troubles de la membrane muqueuse, et pour le soulagement de la douleur
CA2132416A1 (fr)	1993-09-30	Utilisation de l'inhibiteur de la transglutaminase pour le traitement des cicatrices
AU1117092A (en)	1992-08-27	Treatment of lower urinary tract disorders
WO1997005862A3 (fr)	1997-04-17	Utilisation des aminoacides de base et de leurs derives pour abaisser les taux de ceramide
CA2139385A1 (fr)	1995-08-05	Produits renfermant une proteine liante de g-csf et de tnf
CA2157142A1 (fr)	1996-03-01	Traitement des maladies causees par les desordres de la glande sebacee
CA2113916A1 (fr)	1994-07-23	6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide a action analgesique et anti-inflammatoire
AU2713992A (en)	1993-04-22	Therapeutic agent
AU6328696A (en)	1996-12-30	Treatment of hemoglobinopathies
WO2001010427A3 (fr)	2001-09-20	Utilisation topique d'agents anti-muscarinique
EP0328924A3 (fr)	1991-03-20	Composés de thiénotriazolodiazépine et ses applications pharmaceutiques
CA2120319A1 (fr)	1994-10-01	Compose pharmaceutique pour le traitement des dermatopathies
CA2018791A1 (fr)	1990-12-16	Compose capillaire
NZ303993A (en)	2000-12-22	Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders

Legal Events

Date	Code	Title	Description
2006-10-13	EEER	Examination request
2015-01-20	MKEX	Expiry	Effective date: 20141118